Financhill
Back

IGC Pharma Quote, Financials, Valuation and Earnings

IGC Pharma Price Quote

$0.36
-0.02 (-2.17%)
(Updated: December 21, 2024 at 5:31 AM ET)

IGC Pharma Key Stats

Sell
32
IGC Pharma (IGC) is a Sell

Day range:
$0.33 - $0.38
52-week range:
$0.27 - $0.91
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
22.17
P/B ratio:
3.98%

Volume:
728.3K
Avg. volume:
423.3K
1-year change:
28.04%
Market cap:
$29.4M
Revenue:
$1.3M
EPS:
$-0.18

How Much Does IGC Pharma Make?

Data Unavailable

Is IGC Pharma Growing As A Company?

Data Unavailable

IGC Pharma Stock Price Performance

  • Did IGC Pharma Stock Go Up Last Month?
    IGC Pharma share price went up by 13.71% last month
  • Did IGC's Share Price Rise Over The Last Year?
    IGC share price rose by 28.04% over the past 1 year

What Is IGC Pharma 52-Week High & Low?

  • What Is IGC Pharma’s 52-Week High Share Price?
    IGC Pharma has traded as high as $0.91 over the past 52 weeks
  • What Is IGC Pharma’s 52-Week Low Share Price?
    IGC Pharma has traded as low as $0.27 over the past 52 weeks

IGC Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy IGC Pharma?

Data Unavailable

Is IGC Pharma Cash Flow Positive?

Data Unavailable

IGC Pharma Return On Invested Capital

Data Unavailable

IGC Pharma Earnings Date & Stock Price

  • What Is IGC Pharma's Stock Price Today?
    A single share of IGC can be purchased today for 0.38
  • What Is IGC Pharma’s Stock Symbol?
    IGC Pharma trades on the nyam under the ticker symbol: IGC
  • When Is IGC Pharma’s Next Earnings Date?
    The next quarterly earnings date for IGC Pharma is scheduled on February 14, 2025
  • When Is IGC's next ex-dividend date?
    IGC Pharma's next ex-dividend date is May 1, 2020
  • How To Buy IGC Pharma Stock?
    You can buy IGC Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

IGC Pharma Competitors

  • Who Are IGC Pharma's Competitors?
    Below is a list of companies who compete with IGC Pharma or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Protalix BioTherapeutics Inc (PLX)
    • Palatin Technologies Inc (PTN)

IGC Pharma Dividend Yield

Data Unavailable

IGC Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 33.33%
Revenue: 41.58% 41.58%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable